0000899243-21-002963.txt : 20210122
0000899243-21-002963.hdr.sgml : 20210122
20210122165954
ACCESSION NUMBER: 0000899243-21-002963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210119
FILED AS OF DATE: 20210122
DATE AS OF CHANGE: 20210122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dhingra Kapil
CENTRAL INDEX KEY: 0001456849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 21546582
MAIL ADDRESS:
STREET 1: 39 BLISS AVENUE
CITY: TENAFLY
STATE: NJ
ZIP: 07670
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701541
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET, 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-417-5868
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aset Therapeutics, Inc.
DATE OF NAME CHANGE: 20170321
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-19
0
0001701541
Black Diamond Therapeutics, Inc.
BDTX
0001456849
Dhingra Kapil
C/O BLACK DIAMOND THERAPEUTICS, INC.
ONE MAIN STREET, 10TH FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
27.45
2021-01-19
4
A
0
29842
0.00
A
2031-01-19
Common Stock
29842
29842
D
This option shall vest and become exercisable in thirty-six (36) equal monthly installments following the Grant Date.
/s/ Brent Hatzis-Schoch, as Attorney-in-Fact
2021-01-22